Formycon AG

Formycon AG
Stock Exchange Xetra Stock Exchange
EPS
EUR0.76
Market Cap
EUR288.33 M
Shares Outstanding
9.42 M
Public Float
9.42 M

Profile

Address
Fraunhoferstraße 15
Munich Bayern (Bavaria) 82152
Germany
Employees -
Website http://formycon.com
Updated 07/08/2019
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205 which focusoin the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.

Financials

View All

Hermann Vogt
Deputy Chairman-Supervisory Board
Stefan Glombitza
Chief Operating Officer